Frank Gohring
Inventor
Stats
- 5 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 10 US Applications Filed
- 62 Total Citation Count
- Dec 19, 2014 Most Recent Filing
- Jan 9, 1992 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MANNESMANN VDO AG | 3
| 1999
|
VDO Adolf Schindling AG | 1
1 | 1992
1995 |
ACUITY PHARMACEUTICALS, INC. | 1
| 2005
|
CONTINENTAL AUTOMOTIVE GMBH | 1
| 1996
|
RXI PHARMACEUTICALS CORPORATION | 1
1 1 1 | 2003
2005 2010 2014 |
LYNKEUS BIO TECH GMBH | 1
| 2014
|
LYNKEUS BIOTECH GMBH | 1
| 2004
|
Inventor Addresses
Address | Duration |
---|---|
FRANKFURT, DE | Jan 03, 02 - Jan 03, 02 |
Frankfurt, DE | Dec 22, 92 - Sep 03, 02 |
Wurzburg, DE | Dec 23, 04 - Apr 16, 15 |
Technology Profile
Technology | Matters | |
---|---|---|
A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2015/0105,448 | 2015 | MEANS AND METHODS FOR THE SPECIFIC MODULATION OF TARGET GENES IN THE CNS AND THE EYE AND METHODS FOR THEIR IDENTIFICATION | 0 |
2011/0021,605 | 2011 | MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE | 14 |
2006/0003,915 | 2006 | Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification | 7 |
2005/0222,061 | 2005 | Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye | 7 |
2004/0261,141 | 2004 | Animal model for therapy of diseases of the eye | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.